STUDIES OF HLA CLASS II GENES
STUDIES OF HLA CLASS II GENES
批准号:
3134132
负责人:
FRITZ H BACH
金额:
$28.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-08-01 至 1990-11-30
关键词:
T lymphocyte cell cell interaction gene mutation genetic manipulation genetic mapping genetic recombination histocompatibility antigens human tissue laboratory mouse laboratory rabbit leukocyte antigen typing major histocompatibility complex monoclonal antibody nucleic acid sequence site directed mutagenesis tissue /cell culture transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Studies are proposed to obtain further information about sequences of
expressed HLA class II DR and DQ genes that are responsible for the
expression of determinant recognized by T lymphocytes in allo- or
restricted recognition. Homozygous typing cells (HTCs), from
consanguineous matings wherever possible, will be studied. DR4+ and DR2+
HTCs will be the primary focus of the proposed experiments for several
reasons, including the fact that several "Dw subtypes" of each of these
serologically defined specificities have been defined. Individuals who are
DR4+ can be divided into a number of groups based on the Dw specificities
that they express as defined with HTCs, i.e. specificities recognized by T
lymphocytes; these "subtype" specificities include Dw4, Dw10, Dw13, Dw14,
and Dw15. Likewise, DR2+ individuals can be divided into those expressing
Dw2, Dw12, and LD-MN2. We consider it a special strength of this
application that the same HTCs proposed herein for study by DNA techniques
have been, and are continuing to be, studied in our laboratories including
studies of the DR and DQ proteins, functional characterization of
responding T lymphocytes, and definition of determinants recognized in
allo- and restricted recognition. This should allow correlations of
structure as determined by protocols in the present application with
function and thus allow a better understanding of the molecular basis of
cellular interactions. A number of techniques, including in vivo
recombination, intra-exonic shuffling and site directed mutagenesis, are
proposed to pinpoint precisely which sequences are involved in expression
of determinants recognized by T lymphocytes. Normal and mutagenized genes
will be studied by transfection. In addition, peptides which include
sequences of interest will be evaluated in an antigen presenting cell
system. Attempts will be made to generate monoclonal antibodies/antisera
to determinants of interest. We believe these studies will contribute to
diagnosis by providing the background information needed to study this same
gene family in "disease haplotypes".
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.
通过限制性片段长度多态性 (RFLP) 对无关骨髓移植患者进行 HLA II 类分型。
DOI:
--
发表时间:
1989
期刊:
Transplantation proceedings
影响因子:
0.9
作者:
[Noreen,HJ, Davidson,ML, McCullough,J, Bach,FH, Segall,M]
通讯作者:
Segall,M
The phthiocerol-containing surface lipids of Mycobacterium leprae--a perspective of past and present work.
麻风分枝杆菌含有硫醇的表面脂质——过去和现在工作的视角。
DOI:
--
发表时间:
1983
期刊:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association
影响因子:
--
作者:
[Brennan,PJ]
通讯作者:
Brennan,PJ
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7538400
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7166066
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7327813
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7035144
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase 2005 -- the 4th International Conference
-
批准号:7001754
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:FRITZ H BACH
-
依托单位:
Regulation of Endothleial Cell Apoptosis by HO-1 and CO
-
批准号:6638740
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2001
-
负责人:FRITZ H BACH
-
依托单位:
Regulation of Endothleial Cell Apoptosis by HO-1 and CO
-
批准号:6745108
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2001
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6184287
-
项目类别:
-
资助金额:$32.71万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6389716
-
项目类别:
-
资助金额:$33.42万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:2637613
-
项目类别:
-
资助金额:$31.37万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6056438
-
项目类别:
-
资助金额:$32.03万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
MOLECULAR STUDIES OF NK CELLS AND NK/LAK FUNCTION
-
批准号:3128427
-
项目类别:
-
资助金额:$17.83万
-
财政年份:1992
-
负责人:FRITZ H BACH
-
依托单位:
MOLECULAR STUDIES OF NK CELLS AND NK/LAK FUNCTION
-
批准号:2060837
-
项目类别:
-
资助金额:$31.57万
-
财政年份:1992
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:3365969
-
项目类别:
-
资助金额:$9.73万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:3365970
-
项目类别:
-
资助金额:$11.8万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:2223218
-
项目类别:
-
资助金额:$13.25万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
ESTABLISHMENT OF UPGRADED FLOW CYTOMETRY SYSTEM CORE
-
批准号:3520383
-
项目类别:
-
资助金额:$31.5万
-
财政年份:1988
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134131
-
项目类别:
-
资助金额:$27.47万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134129
-
项目类别:
-
资助金额:$22.84万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134130
-
项目类别:
-
资助金额:$26.72万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
海外基金